| Outcome Measures: |
Primary: Delta AUCBG,0-2h, Incremental area under the blood glucose concentration-time curve from 0-2 hours after a standardised meal, 2 hours | Secondary: Delta AUCBG,0-6h, Incremental area under the blood glucose concentration-time curve from 0-6 hours after a standardised meal, 6 hours|BGmax, Maximum blood glucose concentration after a standardised meal (0-6 hours), 6 hours|tBGmax, Time to maximum blood glucose concentration after a standardised meal (0-6 hours), 6 hours|AUCLisp,0-6h,, Area under the plasma insulin lispro concentration-time curve from 0-6 hours, 6 hours|AUCGlarg,0-6h, Area under the plasma insulin glargine concentration-time curve from 0-6 hours, 6 hours|Cmax,Lisp, Maximum observed plasma insulin lispro concentration, 6 hours|Cmax,Glarg, Maximum observed plasma insulin glargine concentration, 6 hours|Adverse events, Number of adverse events, Up to 7 weeks|Local tolerability, Number and intensity of injection site reactions, Up to 7 weeks
|
